KRT7 and breast cancer: In a review, Tot et al. found the following CK7/CK20 rates in patients with breast cancer: CK7-positive/CK20-negative, 88%; CK7-negative/CK20-positive, 1%; CK7-positive/CK20-positive, 11% [14].